Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 166 are a BUY (89.25%), 20 are a HOLD (10.75%).
Analyst Robert Driscoll works at WEDBUSH with a stock forecast success ratio of 42.38% fulfilled within 140.24 days on average.
Robert Driscoll’s has documented 365 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALPN, Alpine Immune Sciences at 11-Apr-2024.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$1.36 (51.52%)
4
20 days ago
0/5 (0%)
$1 (33.33%)
Buy
4
$1.36 (51.52%)
6
1 months 23 days ago
1/8 (12.5%)
$1.21 (43.37%)
139
Buy
5
$2.36 (89.39%)
6
1 months 23 days ago
0/13 (0%)
$2.21 (79.21%)
Buy
5
$2.08 (71.23%)
2 years 2 months 22 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
7
2 years 9 months 27 days ago
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?